Reven Pharmaceuticals Stock
Bio-Pharmaceutical Company
Sign up today and learn more about Reven Pharmaceuticals Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Reven Pharmaceuticals Stock
Reven Holdings, Inc. is a development-stage bio-pharmaceutical company that develops and markets propriety solutions for the treatment of cardiovascular and metabolic related conditions.
Funding History
| January 2014 | $1.8M |
|---|---|
| January 2014 | $5.0M |
| February 2015 | $4.4M |
| January 2016 | $10.0M |
| January 2017 | $23.0M |
| January 2019 | $23.0M |
Management
Co-Founder & Chief Executive Officer
Peter Lange
Chief Financial Officer
Jeffrey Halverson
Chief Technology Officer
James Ervin
Chief Operating Officer
Brian Denomme
Chief Medical Officer
Fatih Uckun
Press
prnewswire - Dec, 27 2023
Peripheral Artery Disease Global Market to Surpass USD 54 ...EquityZen Recognized As:
